Improving diagnostic tests for Hepatitis B
Official title: RADx Innovation Funnel for Hepatitis B Diagnostics - Validation Center
Funded at Emory University · NIH-11205647 · Data updated 2026-11-12
This study is working on new, easy-to-use tests for Hepatitis B that can give you results faster and help you get the care you need more quickly, making it easier for patients to get diagnosed and treated.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project start | September 30, 2024 |
| Project end | September 29, 2026 |
| Funding year | 2024 |
| Award (this year) | $410,000 |
| NIH project number | 75N92022D00015-0-759202400003-2 |
| Project ID | NIH-11205647 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals at risk for Hepatitis B or those who require testing for the virus.
✕Less likely to help
Patients who are not at risk for Hepatitis B or who have already been diagnosed and are receiving treatment may not benefit from this research.
What this research studies
This research focuses on developing and validating innovative point-of-care diagnostic technologies for Hepatitis B. By utilizing the Rapid Acceleration of Diagnostics (RADx) program, the project aims to enhance the accuracy and reliability of tests that can be used in various healthcare settings. Patients may benefit from quicker and more accessible testing options, which can lead to timely diagnosis and treatment. The approach involves rigorous evidence generation to ensure that the new diagnostic tools meet high standards of quality.
Why it matters
Potential benefit: If successful, this research could provide patients with faster and more accurate Hepatitis B diagnostic tests.
How similar studies have gone: Other research initiatives have successfully developed rapid diagnostic tests for various conditions, indicating a promising potential for similar advancements in Hepatitis B diagnostics.
Where this research is happening
-
Emory University
Atlanta, United States Active
Researchers
- Principal investigator: Lam, Wilbur — Emory University
- Study coordinator: Lam, Wilbur
Related research
Other NIH-funded projects on the same topics.
-
HBV cure clues in people with and without HIV
This project studies how HBV-specific B and T cell responses relate to curing hepatitis B in people with and without HIV.
-
HBV cure factors in people with and without HIV
This project studies how HBV-specific immune cells behave during treatment and whether people with HIV respond differently than those without HIV.
-
HBV prevention in community pharmacies: a first step in a low-resource setting
This pilot project tests whether hepatitis B screening and vaccination can be integrated into everyday community pharmacy services to reach more people.
-
Blood markers to catch early liver cancer in Hispanic people with hepatitis B
This project will see if a blood test can find liver cancer earlier in Hispanic people who have chronic hepatitis B.
-
Early blood markers to find hepatitis B–related liver cancer in Hispanics
This project will use immune-related blood markers to find liver cancer earlier in people with chronic hepatitis B, focusing on Hispanic adults.
-
HBV safety with long-acting HIV therapy for people with HIV
A study to understand how long-acting HIV meds affect hepatitis B in people living with HIV and how to best monitor and protect them.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.